With 2025 marking a "reset year for the industry," Oscar Health put a focus throughout the year in setting the company up for the future, its top brass told investors Tuesday.
Centene Corporation, CVS Health, Elevance Health and others had received a voluntary request back in December.
Solace Health advocates help Medicare and MA patients navigate care. The company is now valued at $1 billion.
CVS Health CEO David Joyner told investors on Tuesday that the recently proposed rates for the 2027 Medicare Advantage plan year don't fully account for the current environment.
Garner Health, a digital care navigation company for employers, pocketed $118 million in series D funding to build out its doctor ranking platform.
The Trump administration is aiming to roll back limits on the plan designs insurers can offer in the Affordable Care Act's exchanges.
The One Mind Accelerator is a 10-week program that offers industry expertise and support for fundraising, business development, company growth and founder advancement.
Doximity aims to address trust and safety concerns about AI-driven clinical decision support. It developed PeerCheck, with more than 10,000 medical experts, to bring physician verification and peer review to AI-generated answers.
The integrated care nonprofit said its health plan, hospitals, Risant Health subsidiary and other business under its umbrella combined for $127.7 billion in revenues in 2025, a 10.3% year-over-year increase.
Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new oral weight loss medicine. But the reaction to the move has caused the company to quickly retreat.
Aledade added more than 700 primary care practices to its network for 2026 as the company sees strong tailwinds for value-based care growth.
After years of conversation, legislators pushed key reforms to pharmacy benefit managers over the finish line, much to the chagrin of the industry.
A merger agreement between virtual primary care companies Premise Health and Crossover Health, updates on bankruptcy bids for Prospect Medical Holdings hospitals and more M&A news from January.
The DOJ said MultiCare had allowed a former physician to perform spinal surgery procedures at its facilities between 2019 and 2021 despite warnings from two employees and the U.S. Attorney's Office.
Tucked into the FY2026 government funding bill is legislation that expands the types of providers allowed to offer diabetes prevention programs under the CMMI MDPP Expanded Model.
Molina Healthcare's share price plunged on Friday as it posted a $160 million loss in the fourth quarter as well as guidance for 2026 that fell short of analysts' expectations.
Insurers testifying to Congress last month again promised they are committed to lowering costs, reducing friction and improving transparency. Sustained follow-through has been harder to find, writes Brandon Edwards, CEO and co-founder of Unlock Health.
“FDA will take swift action against companies mass-marketing illegal copycat drugs, claiming they are similar to FDA-approved products,” FDA commissioner Marty Makary, M.D., said in a Feb. 5 post on X. The comments mark a clear and sharp rebuttal to Hims’ announcement earlier in the day that it had launched a compounded version of Novo Nordisk’s new Wegovy pill for obesity, just weeks after Novo's own launch.
Keep up with all the venture capital dollars being funneled into the health tech and digital health industries.
Centene Corporation posted a $1.1 billion loss in the fourth quarter of 2025 as it works to find ways to adapt to the elevated cost environment.
a feed of the latest articles on our website
